Next Article in Journal
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV
Next Article in Special Issue
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study
Previous Article in Journal
Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy
 
 
Article

Article Versions Notes

Cancers 2023, 15(14), 3639; https://doi.org/10.3390/cancers15143639
Action Date Notes Link
article xml file uploaded 15 July 2023 12:37 CEST Original file -
article xml uploaded. 15 July 2023 12:37 CEST Update https://www.mdpi.com/2072-6694/15/14/3639/xml
article pdf uploaded. 15 July 2023 12:37 CEST Version of Record https://www.mdpi.com/2072-6694/15/14/3639/pdf
article supplementary file uploaded. 15 July 2023 12:37 CEST - https://www.mdpi.com/2072-6694/15/14/3639#supplementary
article html file updated 15 July 2023 12:38 CEST Original file -
article html file updated 20 July 2023 22:36 CEST Update https://www.mdpi.com/2072-6694/15/14/3639/html
Back to TopTop